Imidazoline/guanidinium binding sites and their relation to inhibition of K-ATP channels in pancreatic B-cells

被引:34
作者
Rustenbeck, I
Herrmann, C
Ratzka, P
Hasselblatt, A
机构
[1] Inst. of Pharmacology and Toxicology, University of Göttingen, D-37075 Göttingen
关键词
imidazoline binding sites; H-3]clonidine binding; K-ATP channels; pancreatic B-cells; imidazoline compounds; guanidinium compounds;
D O I
10.1007/PL00005070
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To elucidate the beta-cytotropic effect of imidazoline compounds their inhibitory effect on ATP-dependent K+ channels (K-ATP channels) in pancreatic B-cells was compared with their binding to membranes from insulin-secreting HIT T15 cells. K-ATP channels in inside-out patches from B-cells were closed with the following rank order of efficacy at 10 mu M: guanabenz > phentolamine = alinidine > clonidine > idazoxan > rilmenidine = amiloride. The last four compounds achieved an incomplete inhibition only. In contrast to sulfonylureas, the inhibitory action of imidazolines was not enhanced by ADP. With intact cells the site which mediates inhibition is less easily accessible for protonated compounds, suggesting a location at the inner face of the plasma membrane. Competition binding experiments were performed by masking alpha-adrenoceptors and using [H-3]clonidine as Ligand. Homologous displacement of [H-3]clonidine revealed two distinct binding sites in HIT cell membranes characterized by dissociation constants of 38 nM and 4,911 nM and maximal binding capacities of 118 fmol/mg protein and 18 pmol/mg protein. Generally, ligands for I-2 imidazoline receptors were more potent than ligands for I-1 imidazoline receptors to displace [H-3]clonidine from the high affinity site, which does not fit into the current classification of imidazoline receptors. Binding to the second site had affinities in the micromolar range, similar to the concentrations necessary to inhibit K-ATP channels in B-cells. However, alinidine and phentolamine inhibited K-ATP channels already at concentrations at which they displaced [H-3] clonidine only from the high affinity site, but not yet from the low affinity site. Since the proportion of the low and high affinity site varied in dependence of the competitor, the imidazoline binding sites in HIT cells may not be independent, but may rather represent two interacting or interconvertible sites both of which may be involved in K-ATP channel closure.
引用
收藏
页码:410 / 417
页数:8
相关论文
共 53 条
[1]   EFFECTS OF ALPHA-ADRENOCEPTOR BLOCKADE BY PHENTOLAMINE ON BASAL AND STIMULATED INSULIN-SECRETION IN THE MOUSE [J].
AHREN, B ;
LUNDQUIST, I .
ACTA PHYSIOLOGICA SCANDINAVICA, 1985, 125 (02) :211-217
[2]   CLONIDINE-DISPLACING SUBSTANCE (CDS) AND ITS PUTATIVE IMIDAZOLINE RECEPTOR - NEW LEADS FOR FURTHER DIVERGENCE OF ALPHA-2-ADRENERGIC RECEPTOR ACTIVITY [J].
ATLAS, D .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (11) :1541-1549
[3]   EVIDENCE FOR 2 DIFFERENT IMIDAZOLINE SITES ON PANCREATIC B-CELLS AND VASCULAR BED IN RAT [J].
BERDEU, D ;
GROSS, R ;
PUECH, R ;
LOUBATIERESMARIANI, MM ;
BERTRAND, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 275 (01) :91-98
[4]  
BERRIDGE T L, 1986, British Journal of Pharmacology, V89, p671P
[5]   THE IMIDAZOLINE SITE INVOLVED IN CONTROL OF INSULIN-SECRETION - CHARACTERISTICS THAT DISTINGUISH IT FROM I-1-SITE AND I-2-SITE [J].
CHAN, SLF ;
BROWN, CA ;
SCARPELLO, KE ;
MORGAN, NG .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (04) :1065-1070
[6]   THE ALPHA-2-ADRENOCEPTOR ANTAGONIST EFAROXAN MODULATES K+ATP CHANNELS IN INSULIN-SECRETING CELLS [J].
CHAN, SLF ;
DUNNE, MJ ;
STILLINGS, MR ;
MORGAN, NG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 204 (01) :41-48
[7]   STIMULATION OF INSULIN-SECRETION BY THE IMIDAZOLINE ALPHA-2-ADRENOCEPTOR ANTAGONIST EFAROXAN IS MEDIATED BY A NOVEL, STEREOSELECTIVE, BINDING-SITE [J].
CHAN, SLF ;
BROWN, CA ;
MORGAN, NG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 230 (03) :375-378
[8]   STIMULATION OF INSULIN-SECRETION BY EFAROXAN MAY INVOLVE INTERACTION WITH POTASSIUM CHANNELS [J].
CHAN, SLF ;
MORGAN, NG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 176 (01) :97-101
[9]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[10]   CALCULATING RECEPTOR NUMBER FROM BINDING EXPERIMENTS USING SAME COMPOUND AS RADIOLIGAND AND COMPETITOR [J].
DEBLASI, A ;
OREILLY, K ;
MOTULSKY, HJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (06) :227-229